Andrew is a post-doctoral fellow in the Ebert Lab and a member of the Cancer Program at the Broad. His current work is focused on interrogating the function of currently ‘undruggable’ targets in acute myeloid leukemia and understanding the role of splicing factor mutations in myelodysplastic syndrome. Andrew trained as a hematologist in Australia before embarking on a PhD in myelodysplastic syndrome at the Australian Centre for Blood Diseases. His primary interest as a BRCL fellow is to coach scientists on how to effectively communicate their ideas through visual presentation, grant applications, and other modes of communication. Outside the Broad, Andrew enjoys reading, learning piano, running, and learning and adopting productivity approaches and mindfulness techniques.